Chan-Hui; Po-Ying

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chan-Hui; Po-Ying.The latest application filed is for "monoclonal antibodies directed against trimeric forms of the hiv-1 envelope glycoprotein with broad and potent neutralizing activity".

Company Profile

9.26.37

Chan-Hui; Po-Ying - Bellevue WA
Chan-Hui; Po-Ying - Oakland CA
Chan-Hui; Po-Ying - Mayne Island CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies Grant 11,319,362 - Chan-Hui , et al. May 3, 2	2022-05-03
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Activity App 20210040186 - Chan-Hui; Po-Ying ; et al.	2021-02-11
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 10,865,234 - Chan-Hui , et al. December 15, 2	2020-12-15
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Grant 10,836,811 - Chan-Hui , et al. November 17, 2	2020-11-17
Broadly Neutralizing Human Immunodeficiency Virus Type 1 (hiv-1) Gp120-specific Monoclonal Antibody App 20200024330 - Chan-Hui; Po-Ying ; et al.	2020-01-23
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Acti App 20190338017 - Chan-Hui; Po-Ying ; et al.	2019-11-07
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 10,407,493 - Chan-Hui , et al. Sept	2019-09-10
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Acti App 20190169273 - Chan-Hui; Po-Ying ; et al.	2019-06-06
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 10,239,934 - Chan-Hui , et al.	2019-03-26
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Activity App 20190031742 - Chan-Hui; Po-Ying ; et al.	2019-01-31
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Grant 10,087,239 - Chan-Hui , et al. October 2, 2	2018-10-02
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 9,920,111 - Chan-Hui , et al. March 20, 2	2018-03-20
Broadly Neutralizing Human Immunodeficiency Virus Type 1 (hiv-1) Gp120-specific Monoclonal Antibody App 20180057570 - Chan-Hui; Po-Ying ; et al.	2018-03-01
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Grant 9,464,131 - Chan-Hui , et al. October 11, 2	2016-10-11
Broadly Neutralizing Human Immunodeficiency Virus Type 1 (hiv-1) Gp120-specific Monoclonal Antibody App 20160264649 - Chan-Hui; Po-Ying ; et al.	2016-09-15
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Activity App 20150218257 - Chan-Hui; Po-Ying ; et al.	2015-08-06
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 9,051,362 - Chan-Hui , et al. June 9, 2	2015-06-09
Human Rhinovirus (HRV) Antibodies App 20140341923 - Chan-Hui; Po-Ying	2014-11-20
Human rhinovirus (HRV) antibodies Grant 8,822,651 - Chan-Hui September 2, 2	2014-09-02
Human Immunodeficiency Virus (hiv)-neutralizing Antibodies App 20140205612 - Chan-Hui; Po-Ying ; et al.	2014-07-24
Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies Grant 8,609,101 - Chan-Hui , et al. December 17, 2	2013-12-17
Methods for detecting receptor complexes comprising PI3K Grant RE44,437 - Chan-Hui , et al. August 13, 2	2013-08-13
Human Rhinovirus (HRV) Antibodies App 20130052163 - Chan-Hui; Po-Ying	2013-02-28
Measuring receptor homodimerization Grant 8,247,180 - Pidaparthi , et al. August 21, 2	2012-08-21
Human Immunodeficiency Virus (hiv)-neutralizing Antibodies App 20110044994 - Chan-Hui; Po-Ying ; et al.	2011-02-24
ErbB Surface Receptor Complexes as Biomarkers App 20100291594 - CHAN-HUI; Po-Ying ; et al.	2010-11-18
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Neutralizing Antibodies App 20100291075 - Chan-Hui; Po-Ying ; et al.	2010-11-18
Methods for detecting receptor complexes comprising PI3K Grant 7,648,828 - Chan-Hui , et al. January 19, 2	2010-01-19
Measuring Receptor Homodimerization App 20090155818 - Pidaparthi; Sailaja ; et al.	2009-06-18
Surface Receptor Complexes as Biomarkers App 20090111127 - Chan-Hui; Po-Ying ; et al.	2009-04-30
Detecting and Profiling Molecular Complexes App 20090011432 - Chan-Hui; Po-Ying ; et al.	2009-01-08
Receptor Tyrosine Kinase Signaling Pathway Analysis For Diagnosis And Therapy App 20090011440 - Mukherjee; Ali ; et al.	2009-01-08
Erbb Heterodimers As Biomarkers App 20080187948 - Chan-Hui; Po-Ying ; et al.	2008-08-07
Measuring receptor homodimerization Grant 7,402,398 - Pidaparthi , et al. July 22, 2	2008-07-22
Detecting and profiling molecular complexes Grant 7,402,397 - Chan-Hui , et al. July 22, 2	2008-07-22
Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy Grant 7,402,399 - Mukherjeei , et al. July 22, 2	2008-07-22
Multiplex analysis using membrane-bound sensitizers Grant 7,217,531 - Singh , et al. May 15, 2	2007-05-15
Profiling frequencies of receptor heterodimers Grant 7,135,300 - Chan-Hui , et al. November 14, 2	2006-11-14
Multiplexed immunohistochemical assays using molecular tags Grant 7,122,319 - Liu , et al. October 17, 2	2006-10-17
Detecting receptor oligomerization Grant 7,105,308 - Chan-Hui , et al. September 12, 2	2006-09-12
Methods and compositions for screening cell binding molecules App 20060166282 - Singh; Sharat ; et al.	2006-07-27
Multiplex analysis using membrane-bound sensitizers App 20060024846 - Singh; Sharat ; et al.	2006-02-02
Multiplex analysis using membrane-bound sensitizers Grant 6,949,347 - Singh , et al. September 27, 2	2005-09-27
Methods for Detecting Receptor Complexes Comprising PDGFR App 20050170438 - Chan-Hui, Po-Ying ; et al.	2005-08-04
Methods for Detecting Receptor Complexes Comprising PI3K App 20050170439 - Chan-Hui, Po-Ying ; et al.	2005-08-04
ErbB surface receptor complexes as biomarkers App 20050130238 - Chan-Hui, Po-Ying ; et al.	2005-06-16
Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy App 20050131006 - Mukherjee, Ali ; et al.	2005-06-16
Measuring receptor homodimerization App 20050089940 - Pidaparthi, Sailaja ; et al.	2005-04-28
Detecting and profiling molecular complexes App 20050079565 - Chan-Hui, Po-Ying ; et al.	2005-04-14
ErbB surface receptor complexes as biomarkers App 20040229294 - Chan-Hui, Po-Ying ; et al.	2004-11-18
ErbB heterodimers as biomarkers App 20040229380 - Chan-Hui, Po-Ying ; et al.	2004-11-18
Surface receptor complexes as biomarkers App 20040229293 - Chan-Hui, Po-Ying ; et al.	2004-11-18
Profiling frequencies of receptor heterodimers App 20040197835 - Chan-Hui, Po-Ying ; et al.	2004-10-07
Cell-screening assay and composition App 20040175765 - Singh, Sharat ; et al.	2004-09-09
Detecting receptor oligomerization App 20040126818 - Chan-Hui, Po-Ying ; et al.	2004-07-01
Multiplexed immunohistochemical assays using molecular tags App 20040121382 - Liu, Linda ; et al.	2004-06-24
Multiplex analysis using membrane-bound sensitizers App 20030170915 - Singh, Sharat ; et al.	2003-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.